Sort
8,912 grants matching “sars cov 2”
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
$553,087Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2024 · CA
CEIRR: COVID-19 Research Activities
$553,082Andrew Pekosz · Johns Hopkins University · N01 · FY2024 · AI
Training Program in Substance Use, HIV and Related Infections
$552,749Natasha Martin · University Of California, San Diego · T32 · FY2023 · DA
Informatics Driven Real-World Analysis of SARS-CoV-2 Serologic Response and In-Vitro Diagnostic Accuracy
$552,000Joseph Solomon Ross · Yale University · U01 · FY2020 · FD
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
$551,675Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Betacoronaviruses: activation and antagonism of host innate immune responses
$551,469Susan R. Weiss · University Of Pennsylvania · R01 · FY2025 · AI
Betacoronaviruses: activation and antagonism of host innate immune responses
$551,469Susan R. Weiss · University Of Pennsylvania · R01 · FY2024 · AI
Coordinated regeneration of lung epithelial and endothelial compartments
$551,304Andrew Vaughan · University Of Pennsylvania · R01 · FY2025 · HL
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
$551,250Rama K Mallampalli · Ohio State University · R33 · FY2022 · HL
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
$551,047Rama K Mallampalli · Ohio State University · R33 · FY2023 · HL
CEIRS - SARS-CoV-2 Research Activities
$550,497Walter A. Orens · Emory University · N01 · FY2021 · AI
Mechanism of Light-activated Antiviral Activity of Conjugated Polyelectrolyte Polymers and Oligomers
$550,000Eva Y Chi · University Of New Mexico · · FY2021 · MPS
CDS&E: Simulation- and Data-driven Peptide Antibody Design Targeting RBD and non-RBD Epitopes of SARS-CoV-2 Spike Protein
$549,351Baofu Qiao · Cuny Baruch College · · FY2022 · ENG
CDS&E: Simulation- and Data-driven Peptide Antibody Design Targeting RBD and non-RBD Epitopes of SARS-CoV-2 Spike Protein
$549,351Baofu Qiao · Northwestern University · · FY2022 · ENG
Coordinated regeneration of lung epithelial and endothelial compartments
$549,195Andrew Vaughan · University Of Pennsylvania · R01 · FY2022 · HL
Development of a safe and effective RBD-based vaccine against MERS-CoV
$549,181Peter J Hotez · Baylor College Of Medicine · R56 · FY2020 · AI
Pragmatic RCT of a multi-level mechanistically informed community intervention to prevent the onset of behavioral health symptoms among socioeconomically disadvantaged pandemic affected children
$548,936Tara Leytham-Powell · University Of Illinois At Urbana-Champaign · R01 · FY2024 · MH
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$548,803Mark R Denison · Vanderbilt University Medical Center · R01 · FY2016 · AI
Leveraging community-based behavioral health to increase vaccine uptake in Latinx adults with mental illness
$548,734Kirsten Davison · Boston College · R01 · FY2023 · NR
Clinical and translational evaluation of vaccination strategies for Zika, Chikungunya, Dengue, Leishmania, Malaria, and other important or emerging vector-borne diseases
$548,539Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A geroscience approach for investigating resilience to SARS-CoV-2 pathology in mice with Alzheimer's disease
$548,438Warren C. Ladiges · University Of Washington · R01 · FY2021 · AG
The tale of two pandemics: Understanding racial and ethnic disparities from the collision of HIV and COVID-19 in the U.S.
$548,386Rena Chiman Patel · University Of Alabama At Birmingham · R01 · FY2024 · MH
Immune Phenotyping Core
$548,082Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Increasing representation of Black communities in COVID-19 home testing and surveillance data
$547,535Heather Bradley · Emory University · U01 · FY2023 · MD
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
$547,502Steffanie A Strathdee · University Of California, San Diego · R01 · FY2022 · DA